Global X Genomics and Biotechnology ETF (GNOM) |
| 47.807 0.367 (0.77%) 02-26 16:00 |
| Open: | 47.59 |
| High: | 47.81 |
| Low: | 47.59 |
| Volume: | 3,389 |
| Market Cap: | 52(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management - Global |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 51.42 |
| Resistance 1: | 48.98 |
| Pivot price: | 46.54 |
| Support 1: | 45.03 |
| Support 2: | 37.47 |
| 52w High: | 51.42 |
| 52w Low: | 27.2 |
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 24 Feb 2026
Behavioral Patterns of GNOM and Institutional Flows - Stock Traders Daily
Thu, 19 Feb 2026
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026 - TipRanks
Mon, 16 Feb 2026
Top ETFs Tracking CRISPR Gene Editing for 2026 - The Motley Fool
Fri, 13 Feb 2026
(GNOM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Wed, 11 Feb 2026
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - US News Money
Tue, 10 Feb 2026
5 Small-cap Biotech ETFs to Watch - Nasdaq
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
